other material
confidence high
sentiment neutral
materiality 0.60
Pieris Pharmaceuticals increases ATM offering capacity to $75M under amended Jefferies agreement
PALVELLA THERAPEUTICS, INC.
- As of Nov 4, 2022, Pieris had sold $33.6M of stock under the prior $50M ATM program.
- Amendment raises aggregate offering amount to $75M, exclusive of shares previously sold.
- Jefferies will use commercially reasonable efforts for at-the-market sales on Nasdaq.
- Company is not obligated to sell any shares; other terms of the Sales Agreement unchanged.